THE CHALLENGE Medical Affairs (MA) at a large global pharmaceutical company required a structured framework to transition products into the late-lifecycle products portfolio. The organization needed a consistent and optimized approach through the development of an adaptable, modular framework to account for product diversity and situation. OUR APPROACH Vynamic mapped the internal organization across functions …
THE CHALLENGE In order to support Key Opinion Leader (KOL)- specific engagement activities, our client desired a more complete understanding of intended launch markets . They were seeking to design and implement activities to support the launch of a product in two emerging markets. OUR APPROACH Vynamic conducted a gap analysis of the client’s target …
THE CHALLENGE A pharmaceutical company was looking to understand the sizes, structures, responsibilities, and future trends to Medical Affairs in other pharmaceutical companies in order to define roles and responsibilities of their Global Medical Affairs Department. OUR APPROACH Vynamic conducted in-depth benchmarking interviews with Medical Affairs executives from eight top-tier pharmaceutical companies across the industry, …
THE CHALLENGE A Commercial Brand Lead identified the need to investigate feasible brand protection options for a major oncology brand that was approaching Loss of Exclusivity (LOE). Significant changes to market share and brand positioning were anticipated due to in-class competitor brands and generic entries, as well as new pipeline launches. There was a need …
THE CHALLENGE A global pharmaceutical client approached Vynamic for support to launch a new operating model for Medical Science Liaisons (MSL) to optimize medical and clinical collaboration for prioritized disease area studies. OUR APPROACH Vynamic conducted in-depth surveys to identify institutional, attitudinal, and functional preferences to enable multiple potential segmentation approaches. To identify the optimal …
THE CHALLENGE A global pharmaceutical client approached Vynamic for support to launch a new operating model for Medical Science Liaisons (MSL) to optimize medical and clinical collaboration for prioritized disease area studies. OUR APPROACH Vynamic partnered with client core team representatives from Field Medical, Global Medical Affairs, and Global Clinical to first identify all stakeholders, …
THE CHALLENGE Medical Affairs Director at a large pharmaceutical company was looking to create an operating model for the company-wide transition of products in their late-lifecycle portfolio. This company required a Global Medical Affairs (GMA)-owned, adaptable, and modular framework that integrates with all business functions and leverages industry best practices. OUR APPROACH Vynamic leveraged deep …
THE CHALLENGE A pharmaceutical company was looking to develop a successful global brand strategy and launch readiness plan for a novel oncology drug. The company wanted cross-functional collaboration on the brand vision and positioning statement from the Global and Affiliate teams. OUR APPROACH Vynamic gathered internal and external materials and combined it with internal stakeholder …
THE CHALLENGE An International Business Leader and International Medical Lead were looking for key strategic questions to be addressed to optimize the clinical development strategy across two oncology indications. OUR APPROACH Vynamic interviewed internal stakeholders across Global and Affiliate teams to ensure inputs from the wider business were taken into consideration when developing the key …
THE CHALLENGE Sales and Marketing teams within a global life sciences company lacked the information, framework, and tools to optimize commercial resourcing decisions at the local level – which in turn would help to better inform brand planning at the National level. A Vynamic team was asked to help mobilize capabilities that leveraged data driven …
